Table 1.
Demographic and clinical findings of the study groups
|
MIS-C (n = 25) |
COVID-19 (n = 20) |
Control (n = 19) |
|
|---|---|---|---|
| Age/years | 7 (5–10) | 9.5 (5.2–11) | 8 (7–10) |
| Body weight (kg) | 28 (20–43) | 41.5 (20.5–59.7) | 32 (26–37) |
| Height (cm) | 124 (115–145) | 137 (114–156) | 133 (120–140) |
| Body mass index (BMI) (kg/m2) | 17.8 (15.9–22.0) | 20.2 (15.7–24.1) | 18.9 (16.6–21.9) |
| Presence of overweight/obesity (n/%) | |||
| Overweight (85–95th p) | 9/25 (36) | 7/20 (3) | 0/19 (0) |
| Obese (> 95th p) | 5/25 (20) | 5/20 (25) | 0/19 (0) |
| Symptoms* (n/100) | |||
| Fever | 25/25 (100) | 15/20 (75) | |
| Cough | 4/25 (16) | 10/20 (50) | |
| Runny nose | 2/25 (8) | 5/20 (40) | |
| Diarrhea | 14/25 (56) | 5/20 (40) | |
| Tachypnea | 5/25 (20) | 5/20 (40) | |
| Myalgia | 12/25 (48) | 7/20 (35) | |
| Abdominal pain | 18/25 (72) | 6/20 (30) | |
| Headache | 9/25 (36) | 7/20 (35) | |
| System involvement** (n/%) | |||
| Hematological | 18/25 (72) | ||
| Gastrointestinal | 16/25 (64) | ||
| Cardiovascular | 10/25 (40) | ||
| Dermatological | 8/25 (32) | ||
| Respiratory | 5/25 (20) | ||
| Neurological | 2/25 (8) | ||
*Most patients had more than one symptom. **Most patients had more than one system involvement